Super Bowl Therapy…Venture Capital Style

MIAMI--(BUSINESS WIRE)--My Therapy Journal.com (www.MyTherapyJournal.com) has been selected as one of only 19 best private companies in Florida to present at the 2009 Florida Venture Capital Conference (known as the Super Bowl of Venture Capital) that will be held on February 3-4 at the Naples Grande Beach Resort in Naples. MyTherapyJournal.com is the only company invited via an academic competition. Winning runner-up in the University of Miami Rothschild Business Plan Competition allowed them to then present at the very competitive Florida Sunshine State Venture Challenge, (Florida’s Statewide Business Plan Competition). Awarded first place by the distinguished judges, provided MyTherapyJournal.com the once-in-a-lifetime opportunity to present at The Florida Venture Forum.

“We have revenues from existing members, but we need funding to grow our existing business while creating new online tools and services. Our goal is to showcase how our business can provide investors with best-in-class returns on their investment”

MyTherapyJournal.com is a pioneer in providing a secure, easy-to-use online journal that is an alternative to traditional diaries. Journal keeping has been endorsed for its therapeutic benefits, often in conjunction with professional counseling. Rodolfo Saccoman, CEO and co-founder says, “According to the U.S. Surgeon General, there are nearly 58 million Americans diagnosable with a mental or substance abuse disorder and only 8% receive any type of services. That’s an addressable market of 4.6 million. So there’s a problem, and we have a solution. For example, there are 300,000 military veterans suffering from Post-Traumatic Stress Disorder (PTSD) and journaling is an important tool in their recovery process.”

Based on the principles of cognitive behavioral therapy, this membership-based service is revolutionizing therapy via the online medium. It gives members control over their path to self-discovery and self-fulfillment. Members write about their thoughts, feelings, memories, dreams, or create personal journals as a way to deal with problems relating to anxiety, depression, substance abuse, among other conditions. Additionally, its category-defining feature – a personal Progress Graph – lets users chart their progress by responding to pre-set questions or creating customized questions. This innovative service is being used independently or in conjunction with professional therapy. Existing users include treatment centers, hospitals, therapists, and individual members. You can take a tour of MyTherapyJournal.com by clicking here.

“At the end of the day, we want to make people’s lives better, to help them achieve greater well-being,” says Saccoman who will give his presentation on February 4 and will be available with his team at booth #7 during the conference. He can be reached at 561-351-4987 or at [e-mail]. Saccoman and his team hope that venture capitalists and angel investors will be attracted to their young yet profitable business model. “We have revenues from existing members, but we need funding to grow our existing business while creating new online tools and services. Our goal is to showcase how our business can provide investors with best-in-class returns on their investment,” explains Saccoman.

MyTherapyJournal.com already has attracted thousands of subscribers since its August 2007 launch at the American Psychological Association Convention (APA). It has been featured on FORBES.com, CNBC.com and Yahoo News.

About the Founders

Rodolfo Saccoman, CEO and co-founder, is a graduate of Cornell University School of Hotel Administration, with an MBA from the University of Miami. Over the past decade, he has become an expert at creating Internet ventures into highly successful and profitable businesses. His brother, Alexis Saccoman, Chief Psychology Consultant and co-founder, is a graduate of Brown University, with a Masters degree in Psychology, currently pursuing a doctorate in clinical psychology (Psy.D.) at the California Institute of Integral Studies. Noel Elman, co-founder, is currently pursuing post-doctoral studies at MIT, working on the development of implantable devices for drug-delivery systems and cancer monitoring.